Over-the-counter (OTC) medicines and nutritional supplement companies provide consumers with products to help them live healthier and more comfortable lives. The safety of these products is paramount to CHPA and its member companies.

CHPA is pleased to be working with members of Congress on legislation to address concerns about the safety of drug ingredients manufactured outside the United States. Current federal regulations require that all CHPA member companies follow very specific good manufacturing practices, and CHPA’s members are committed to continuously improving manufacturing processes to ensure the highest quality.

Related links:

• CHPA Letter to Chairman John Dingell on Import Safety Legislation (Sept. 25, 2008)
• CHPA Letter to Chairman John Dingell on Import Safety Legislation (April 24, 2008)
• U.S. House Draft Import Safety Bill
• CHPA Summary of House draft
• U.S. Senate Draft Import Safety Bill
• Senate Staff Summary of Senate Draft Bill
• CHPA Side-by-Side of Import Safety Bills

 Interagency Import Safety Working Group related links:

• Federal Import Safety Action Plan (November 2007)
• Import Safety Action Plan UPDATE (July 2008)